Calliditas Therapeutics: Interim Report Q1, 2022 ...Middle East

STOCKHOLM, May 18, 2022 /PRNewswire/ -- Start of TARPEYO™ Commercial Launch in the US "During the first quarter Calliditas launched its first commercial product, TARPEYO, in the US, supported by 40 experienced specialty sales executives who were trained and in the field in late January....

Hence then, the article about calliditas therapeutics interim report q1 2022 was published today ( Wednesday 18/05/2022 - 08:50 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas Therapeutics: Interim Report Q1, 2022 )

Also on site :

• Nigerian general killed in Islamic State attack
• AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
• The Oil Shock Is Worse Than You Think